04/24/2024
3:07 PM | Sage Therapeutics (Filer)
| Form DEF 14A | |
04/24/2024
3:10 PM | Sage Therapeutics (Filer)
| Form DEFA14A | |
04/24/2024
3:13 PM | Sage Therapeutics (Filer)
| Form ARS | |
04/19/2024
7:31 AM | Sage Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/17/2024
5:35 AM | Sage Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/26/2024
7:34 AM | Sage Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
6:49 AM | Sage Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
|
02/14/2024
6:20 AM | Sage Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/14/2024
6:09 AM | RTW INVESTMENTS, LP (Filed by)
Sage Therapeutics (Subject)
| Form SC 13G | |
02/14/2024
5:45 AM | Sage Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/13/2024
4:13 PM | Sage Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
02/13/2024
5:28 AM | Sage Therapeutics (Subject)
| Form SC 13G/A | |
02/13/2024
5:28 AM | BB BIOTECH AG (Filed by)
BB BIOTECH AG (Filed by)
Sage Therapeutics (Subject)
| Form SC 13G/A | |
02/09/2024
8:49 AM | FMR LLC (Filed by)
Sage Therapeutics (Subject)
| Form SC 13G/A | |
02/08/2024
9:17 AM | Sage Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
01/31/2024
4:25 PM | Sage Therapeutics (Subject)
| Form SC TO-I/A | |
01/31/2024
3:50 PM | Sage Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/24/2024
9:04 AM | Sage Therapeutics (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G | |
01/23/2024
7:13 AM | Sage Therapeutics (Subject)
| Form SC TO-I | |
01/08/2024
5:45 AM | Sage Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/04/2024
3:07 PM | IGUCHI KIMI (Reporting)
Sage Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
3:07 PM | Golumbeski George (Reporting)
Sage Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
3:07 PM | FRATES JAMES M (Reporting)
Sage Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
3:07 PM | PAUL STEVEN M (Reporting)
Sage Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
3:07 PM | Federer Jessica (Reporting)
Sage Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2023
7:30 AM | Sage Therapeutics (Filer)
| Form DEF 14A | |
12/19/2023
7:32 AM | Sage Therapeutics (Filer)
| Form DEFA14A | |
12/08/2023
8:00 AM | Sage Therapeutics (Subject)
| Form SC TO-C | |
12/08/2023
7:30 AM | Sage Therapeutics (Filer)
| Form PRE 14A | |
12/08/2023
7:30 AM | Sage Therapeutics (Filer)
| Form PRE 14A | |
11/07/2023
6:39 AM | Sage Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/07/2023
6:29 AM | Sage Therapeutics (Filer)
| Form 424B5 | |
11/07/2023
6:00 AM | Sage Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/07/2023
5:46 AM | Sage Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/31/2023
5:45 AM | Sage Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/11/2023
7:51 AM | Barrett Elizabeth (Reporting)
Sage Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/07/2023
6:49 AM | Sage Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/07/2023
6:20 AM | Sage Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/07/2023
5:45 AM | Sage Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/10/2023
7:44 AM | Sage Therapeutics (Subject)
| Form SC 13G/A | |
07/10/2023
7:44 AM | Sage Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
Move Your Money Before May 22 (Ad) The SIX WORDS That Could Destroy America... And The Value of Your Savings.
He predicted the dangerous rise of inflation... the death of the 60/40 portfolio... and now, this 40-year market veteran and retirement expert is stepping forward with a new must-see warning for every American. It involves the world's most powerful investors, central bankers, and America's most bitter geopolitical rivals.  Here's where Dr. David Eifrig says to move your money immediately. |
05/11/2023
7:58 AM | Barrett Elizabeth (Reporting)
Sage Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2023
6:21 AM | Sage Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/02/2023
5:45 AM | Sage Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
